Epsom Salt
- Product NDC
- 41250-602
- Requested package NDC
- 41250-602-80
- 11-digit product format
- 412500602
- Labeler code
- 41250
- Product ID
- 41250-602_4b340dae-832a-9be5-e063-6394a90a13b8
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Magnesium Sulfate
- Dosage form
- GRANULE, FOR SOLUTION
- Route
- ORAL; TOPICAL
- Labeler
- Meijer, Inc.
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2013-04-26
- Substance
- MAGNESIUM SULFATE HEPTAHYDRATE
- Active strength
- 1 g/g
- Pharmacologic classes
- Calculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 41250-602 | 41250-602-80 | D | Discontinued by firm | 2026-11-16 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 41250-602 | 41250-602-80 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 41250-602 | 41250-602-80 | D | Discontinued by firm | excluded / ndc_excluded.zip | f5e01cc5f278… | a2eaf40c39c3… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Epsom Salt
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| MAGNESIUM SULFATE HEPTAHYDRATE | 1 g/g |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| SK47B8698T | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1053346 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 2070a4a6-7968-49f2-84ec-53bd1cd82445 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 41250-602-07 | Epsom Salt | 1814 g in 1 POUCH | GRANULE, FOR SOLUTION | 1814 | 17 | |
| 41250-602-43 | Epsom Salt | 454 g in 1 POUCH | GRANULE, FOR SOLUTION | 454 | 17 | |
| 41250-602-80 | Epsom Salt | 3628 g in 1 POUCH | GRANULE, FOR SOLUTION | 3628 | 17 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| MAGNESIUM SULFATE HEPTAHYDRATE | ACTIVE INGREDIENT | SK47B8698T | EPSOM SALT (MAGNESIUM SULFATE) GRANULE, FOR SOLUTION [MEIJER DISTRIBUTION, INC] | 2 | |
| MAGNESIUM CATION | ACTIVE MOIETY | T6V3LHY838 | EPSOM SALT (MAGNESIUM SULFATE) GRANULE, FOR SOLUTION [MEIJER DISTRIBUTION, INC] | 2 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Docusate Sodium | DOCUSATE SODIUM | National Vitamin Company | 0c66642c-82cb-42cd-82bb-5f95852cc5d1 | 2024-12-12 | Warnings | M007 |
| Foster and Thrive Fiber Laxative 147 | CALCIUM POLYCARBOPHIL | Strategic Sourcing Services LLC | 88d341a6-28aa-4a20-bfed-1d5f3106c2ae | 2024-12-12 | Warnings | M007 |
| Pedia-Lax | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC | C.B. Fleet Company, Inc. | f001a37d-8ed4-428b-af12-d6a83c22c127 | 2024-12-12 | Warnings | M007 |
| Careone Milk of magnesia Original Milk of Magnesia Original | MAGNESIUM HYDROXIDE | Retail Business Services, LLC. | 13ffb00b-7c6f-47aa-bc82-2402d121a758 | 2024-12-11 | Warnings | M007 |
| CareOne Milk of Magnesia Cherry | MAGNESIUM HYDROXIDE | Retail Business Services, LLC. | 1822f90d-f693-48d7-b338-a3f2ddfac4df | 2024-12-11 | Warnings | M007 |
| MILK OF MAGNESIA MINT | MAGNESIUM HYDROXIDE | GOOD SENSE | a951b6d0-9182-e1bc-e053-2a95a90a12b1 | 2024-12-09 | Warnings | M007 |
| CITRUCEL | METHYLCELLULOSE | Haleon US Holdings LLC | d27f6742-2dcc-451e-b803-6ffe183038ec | 2024-12-05 | Warnings | M007 |
| Laxacin | DOCUSATE SODIUM AND SENNOSIDES | Alexso, Inc | 0df9abaf-3997-4dde-8003-ae3d8d07cf39 | 2024-12-04 | Warnings | M007 |
| NuValu Epsom Salt | MAGNESIUM SULFATE (HEPTAHYDRATE) | J C SALES | 9f3cf9a4-e5c0-41ff-9fd3-63efb0d973cd | 2024-12-04 | Warnings | M007 |
| NuValu Epsom Salt | MAGNESIUM SULFATE (HEPTAHYDRATE) | J C SALES | 5a503d8d-7899-4b1e-be6f-8e2a759af265 | 2024-12-04 | Warnings | M007 |
| SENNOSIDES | SENNOSIDES | CVS Pharmacy, Inc. | 6dffc3f5-bae0-c436-e053-2991aa0a0f8b | 2024-12-02 | Warnings | M007 |
| Pure and Gentle | MINERAL OIL | Medline Industries, LP | 96d4cad5-0602-4c31-94ed-3117b4fd4a94 | 2024-11-26 | Warnings | M007 |
| Pure and Gentle Laxative | SODIUM PHOSPHATE | Medline Industries, LP | e3165538-75dd-4f0f-adc8-d4075de10f1e | 2024-11-26 | Warnings | M007 |
| DOCUSATE SODIUM 50 MG | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. | af7533e6-8b06-48a4-940e-7ecb57b24b59 | 2024-11-25 | Warnings | M007 |
| DOCUSATE SODIUM 100mg Two-Tone | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. | a923e5ca-86fd-4bf9-9931-180ddfdeae66 | 2024-11-25 | Warnings | M007 |
| DOCUSATE SODIUM 100mg Two-Tone | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd. | 7cf1df18-d658-4bff-8a62-365fc5656942 | 2024-11-25 | Warnings | M007 |
| DOCUSATE SODIUM 100mg | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan) Co., Ltd. | c5bdfbfc-d24a-4088-9b60-ecea8120ff43 | 2024-11-25 | Warnings | M007 |
| DOCUSATE SODIUM | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. | b10fdf50-289e-41f3-9b83-a4e4dd892f88 | 2024-11-21 | Warnings | M007 |
| DOCUSATE SODIUM 100mg Two-Tone | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceutical (Wuhan), Ltd. | 85c64624-428d-46fa-8071-f42b8feec049 | 2024-11-21 | Warnings | M007 |
| Docusate Sodium | DOCUSATE SODIUM | Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd | 33251cb7-b7b1-4f6c-9e10-4fa64cbf03a0 | 2024-11-21 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1053346 | Epsom salt 100 % Granules for Oral Solution | PSN | 2070a4a6-7968-49f2-84ec-53bd1cd82445 | 17 |
| 1053346 | magnesium sulfate 1000 MG Granules for Oral Solution | SCD | 2070a4a6-7968-49f2-84ec-53bd1cd82445 | 17 |
| 1053346 | Epsom salt 100 % Granules for Oral Solution | SY | 2070a4a6-7968-49f2-84ec-53bd1cd82445 | 17 |
| 1053346 | magnesium sulfate 100 % Granules for Oral Solution | SY | 2070a4a6-7968-49f2-84ec-53bd1cd82445 | 17 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 41250-602-80 | 41250060280 | 3629 g in 1 POUCH (41250-602-80) | 3629 g | 2013-04-26 | 0000-00-00 | No | No | Current |